Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Curatio Nets $20m Investment As Dermatology Stays On PE Menu

Executive Summary

Private equity group ChrysCapital is investing $20m in the Indian firm Curatio Healthcare, underscoring the continuing interest in the niche dermatology space that generally sees healthy margins.

You may also be interested in...



Torrent snaps Zyg, builds derma play

Torrent Pharmaceuticals is acquiring the domestic firm, Zyg Pharma - a move that is expected to expand its portfolio to the niche dermatology segment in key international markets.

Sequoia set to invest in Indian derma firm Curatio

Niche verticals continue to draw private equity interest with Sequoia Capital said to be on course to investing around INR1bn ($16.2m) in the Indian specialty dermatology firm, Curatio Healthcare.

IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf

Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC100560

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel